Valuation: Orion Pharma Limited

Market Cap 6.69B 53.57M 48.63M 44.92M 40.53M 76.51M 5.01B 79.44M 541M 214M 2.7B 201M 197M 8.53B P/E 2024
50.8x
P/E 2025 -17.1x
Enterprise Value 32.23B 258M 234M 216M 195M 368M 24.1B 383M 2.61B 1.03B 13.01B 968M 948M 41.1B EV / Sales 2024
3.62x
EV / Sales 2025 7.99x
Free-Float
74.17%
Yield 2024
1.45%
Yield 2025 -
1 day-0.40%
1 week+2.02%
Current month-10.95%
1 month-13.40%
3 months-11.27%
6 months-1.95%
Current year-8.03%
1 week 24.7
Extreme 24.7
26.1
1 month 23.6
Extreme 23.6
30.3
Current year 23.5
Extreme 23.5
33.2
1 year 23.5
Extreme 23.5
33.2
3 years 22.9
Extreme 22.9
91.8
5 years 22.9
Extreme 22.9
156.5
10 years 22.9
Extreme 22.9
156.5
Manager TitleAgeSince
Chief Executive Officer 48 2019-12-31
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman 71 2014-09-09
Director/Board Member 71 1984-12-31
Director/Board Member 68 1996-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%+2.02%+1.61%-68.34% 47.54M
-1.13%+0.25%+38.06%+140.43% 1,275B
-1.36%-1.21%+42.24%+85.68% 680B
-0.59%-0.16%+26.02%+111.76% 521B
-0.76%+1.27%+41.98%+71.50% 389B
-0.75%-3.62%+54.29%+40.57% 356B
-1.83%-0.13%+27.64%+60.13% 305B
-1.65%-1.88%+2.00%+35.77% 287B
-0.95%-1.57%+35.99%+70.23% 250B
+1.60%+0.56%+36.19%+128.48% 208B
Average -0.55%+0.19%+30.60%+67.62% 427B
Weighted average by Cap. -0.64%+0.76%+35.59%+96.15%

Financials

2024 2025
Net sales 10.62B 85.01M 77.18M 71.29M 64.32M 121M 7.94B 126M 859M 340M 4.29B 319M 312M 13.54B 4.08B 32.67M 29.66M 27.4M 24.72M 46.66M 3.05B 48.45M 330M 131M 1.65B 123M 120M 5.2B
Net income 318M 2.55M 2.31M 2.14M 1.93M 3.64M 238M 3.78M 25.73M 10.18M 128M 9.55M 9.35M 406M -415M -3.32M -3.02M -2.79M -2.51M -4.75M -311M -4.93M -33.59M -13.29M -168M -12.47M -12.21M -530M
Net Debt 22.31B 179M 162M 150M 135M 255M 16.68B 265M 1.8B 714M 9B 670M 656M 28.44B 25.54B 204M 186M 171M 155M 292M 19.1B 303M 2.07B 817M 10.31B 767M 751M 32.56B
Projected Income Statement - Annual - Orion Pharma Limited
Logo Orion Pharma Limited
Orion Pharma Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health-related consumer products. It produces diversified dosage forms, like tablets, capsules, syrups, solutions, suspensions, emulsions, powder for suspensions, creams, ointments, and injections. The Company manufactures under different therapeutic categories including antibiotics, antiulcerants, anti-diabetics, cardiovascular, antihistamines, antiemetics, antispasmodics, antifungals, laxatives, NSAIDs, anticancer, vitamins & minerals, and others. The Company's products include Ambronil, Angimet MR, Arovent, Axet, Avison, Azalid, Angimet, Alve, Anvert, Baclon, Betacal, Bisoloc, Bonec, Broket, Bromazep, Boncare, Sefin, Stimulin, Silvage, ROVEX, Rupenta, Rispa, Riz, and others. Its subsidiaries are Dutch Bangla Power & Associates Ltd. and Orion Power Meghnaghat Ltd.
Employees
2,954
Date Price Change Volume
26-11-17 BDT 25.20 -0.40% 353,662
26-11-16 BDT 25.30 +1.61% 193,127
26-11-15 BDT 24.90 -0.80% 312,453
26-11-12 BDT 25.10 -3.09% 433,555
26-11-11 BDT 25.90 +3.19% 326,256
  1. Stock Market
  2. Stocks
  3. ORIONPHARM Stock